2024-09-17 11:00
The annual general meeting of Biovica International AB ("Biovica" or the "Company") was held today on 17 September 2024 and the following resolutions were passed by the meeting. ADOPTION OF THE INCOME STATEMENT AND BALANCE SHEETThe...
2024-09-17 08:30
Biovica, active in blood-based cancer monitoring, has signed a Master Service Agreement (MSA) with a US-based biotech company focusing on next generation CDK inhibitors. Under the agreement, Biovica will provide TKa testing services utilizing Biovica’s...
2024-09-12 10:25
Correction due to missing MAR-legend Significantly increased sales in the USA and much improved cash flow Significant events during the first quarter Significant events after the end of the period Webcast:When: 12 September 2024, 3 PM to 4 PM CETWhere...
2024-09-12 08:00
Significantly increased sales in the USA and much improved cash flow Significant events during the first quarter Significant events after the end of the period Webcast:When: 12 September 2024, 3 PM to 4 PM CETWhere: registration via: Biovica Q1 Earnings...
2024-08-16 08:00
The shareholders of Biovica International AB, reg. no. 556774-6150, (the "Company") are hereby invited to the annual general meeting to be held on Tuesday 17 September 2024, at 10.00 CET in Conference Hubben's premises on Dag Hammarskjölds...
2024-07-25 13:45
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION IN WHICH...
2024-07-15 15:30
The extra general meeting of Biovica International AB ("Biovica" or the "Company") was held today on 15 July 2024 and the following resolutions were passed by the meeting. SHARE SAVINGS PROGRAM 2024/2027:1 FOR SENIOR EXECUTIVES AND...
2024-06-28 08:30
Biovica, a leader in blood-based cancer monitoring, has signed a Master Service Agreement and the initial Work Order with a US-based biopharmaceutical company specializing in breast cancer. The agreement enables Biovica to provide TKa testing services...
2024-06-28 08:00
Annual report for the financial year 2023/2024 for Biovica International AB is published today on our website. See URL below. Contact Anders Rylander, CEOPhone: +46 76 666 16 47E-mail: anders.rylander@biovica.com Anders Morén, CFOPhone: +46 73...
2024-06-27 10:30
The purpose of the extra general meeting that Biovica has called for on July 15, 2024, is to decide on share-based incentive programs for employees and the board of Biovica International AB and subsidiaries. By doing so at an extraordinary general meeting...
>4,500
Numbers of patients in studies
28
Publications
32
Pharma Projects